Peptides
Join host Ben Synth as he examines the booming gray-market peptide trend, including BPC-157, TB-500, and growth hormone secretagogues. This episode explores the critical gap between promising animal studies and unproven human applications, the unregulated supply chain risks, and why comparing research peptides to FDA-approved medications misleads consumers seeking anti-aging and recovery benefits. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
4 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Peptides!